Showing results (271-280 of 316) with videos related to
Sort By:
Pageof 32
British Journal of Cancer|July 27, 2006
Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II studyA W Blackstock, F Mornex, C Partensky, et al.Revue De Pneumologie Clinique|July 26, 2015
[Graft-versus-host disease, a rare complication of lung transplantation]H Morisse-Pradier, R Nove-Josserand, F Philit, et al.Nature Materials|July 29, 2003
The remarkable difference between surface and step atoms in the magnetic anisotropy of two-dimensional nanostructuresS Rusponi, T Cren, N Weiss, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 2, 2022
[Practice changing clinical trials in radiation oncology in 2022]D Antoni, L Claude, A Laprie, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 13, 2016
[Radiotherapy for paediatric cancers]A Laprie, L Padovani, V Bernier, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 31, 2021
Guide for paediatric radiotherapy proceduresA Laprie, V Bernier, L Padovani, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO studyB Chauffert, F Mornex, F Bonnetain, et al.Revue Des Maladies Respiratoires|February 1, 2011
[A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)]J Tredaniel, F Mornex, I Barillot, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 22, 2009
[French radiotherapy database: results of a survey of French radiation oncology centers in 2007]B Chauvet, M Bolla, A Alies-Patin, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2011
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]M Barhoumi, F Mornex, F Bonnetain, et al.Pageof 32